Figure 2.
Transcriptional features of genome-edited MLL-AF9 translocated cells. (A) RT-PCR was performed on complementary DNA of genome-edited MLLr cells from 2 independent cultures to detect fusion transcripts. Closed arrowheads indicate MLL-AF9 and AF9-MLL fusion transcripts. Open arrowheads indicate the alternatively processed fusion transcripts, which lack MLL exon 11 and MLL exon 12 from MLL-AF9 and AF9-MLL, respectively. (B) Representative western blot analysis of MLL proteins in controls (nucleofected with GFP alone) and MLL-AF9–rearranged cells cultured either in liquid or semisolid medium. Retroviral and knock-in indicate transformed human cord blood cells by retroviral MLL-AF9 or MLL-AF9 knock-in. CFC, colony-formed cells; GAPDH, loading control; LC, liquid culture. Numbers below indicate relative MLL-AF9 band intensities compared with WT MLLN. (C) Representative qPCR analyses show expression levels of MLL target genes compared with control (nucleofected with GFP) at day 65 of culture and human leukemia cell lines. *P < .02. Error bars indicate standard deviation of triplicate analyses. MM6, Mono Mac 6; S1, sample 1; S2, sample 2; WT, wild-type.